erlotinib hydrochloride has been researched along with go 6976 in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (go 6976) | Trials (go 6976) | Recent Studies (post-2010) (go 6976) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 504 | 1 | 133 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | go 6976 (IC50) |
|---|---|---|---|
| Protein kinase C gamma type | Homo sapiens (human) | 0.002 | |
| Protein kinase C beta type | Homo sapiens (human) | 0.0041 | |
| Protein kinase C alpha type | Homo sapiens (human) | 0.0027 | |
| Protein kinase C delta type | Homo sapiens (human) | 0.446 | |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | 0.0445 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, E; Heffron, TP; La, H; Lee, HJ; Malek, S; Merchant, M; Pirazzoli, V; Politi, K; Schaefer, G; Settleman, J; Shao, L; Sideris, S; Ubhayakar, S; Yauch, RL; Ye, X | 1 |
1 other study(ies) available for erlotinib hydrochloride and go 6976
| Article | Year |
|---|---|
Noncovalent wild-type-sparing inhibitors of EGFR T790M.
Topics: Acrylamides; Amino Acid Substitution; Animals; Area Under Curve; Base Sequence; Carbazoles; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Immunoblotting; Lung; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, Transgenic; Mutation; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; RNA Interference; Staurosporine; Xenograft Model Antitumor Assays | 2013 |